PTGS2 and pancreatic adenocarcinoma: Gonnermann et al. reported that Colo357 cells (pancreatic adenocarcinoma) develop resistance to γδ T cell lysis by enhancing the expression of cyclooxygenase 2 (Cox-2) [139].